Post by UZH Faculty of Medicine

🔬 Did you know that not all genetic risk factors for Alzheimer's disease operate on the same timeline? A fascinating new study is shedding light on how our DNA influences the earliest stages of cognitive decline. The latest research published in the The EANM Journal investigates how the APOE4 gene, a major genetic risk factor for Alzheimer's, interacts with toxic brain proteins. The findings reveal that APOE4 carriers experience an accelerated spread of tau pathology even at lower levels of amyloid accumulation. Essentially, this specific gene variant facilitates a much earlier and faster spread of disease-causing proteins across connected brain regions. 💡 Why it matters: Unravelling the unique molecular pathways driven by the APOE4 gene provides critical insights for the early prediction of memory loss. These findings open the door to highly personalised interventions, helping clinicians determine the optimal window to initiate treatments and protect brain health long before severe symptoms develop. 👥 A massive congratulations to Valerie Treyer, Anton Gietl, and Christoph Hock from University of Zurich and Universitätsspital Zürich. We also celebrate the cross-institutional collaboration led by first author Débora Peretti and last author Valentina GARIBOTTO at the University of Geneva and HUG - Hopitaux Universitaires de Genève. 📖 Read the full paper here: https://lnkd.in/ewWtim4A (Open Access!) #AlzheimersDisease #Neuroscience #MedicalResearch #DementiaPrevention #APOE4 Tagline: Unlocking the Genetics of Alzheimer's: The Impact of APOE4